153 related articles for article (PubMed ID: 32238911)
41. Genome-wide copy number variation analysis in adult attention-deficit and hyperactivity disorder.
Ramos-Quiroga JA; Sánchez-Mora C; Casas M; Garcia-Martínez I; Bosch R; Nogueira M; Corrales M; Palomar G; Vidal R; Coll-Tané M; Bayés M; Cormand B; Ribasés M
J Psychiatr Res; 2014 Feb; 49():60-7. PubMed ID: 24269040
[TBL] [Abstract][Full Text] [Related]
42. Genetic associations with childhood brain growth, defined in two longitudinal cohorts.
Szekely E; Schwantes-An TL; Justice CM; Sabourin JA; Jansen PR; Muetzel RL; Sharp W; Tiemeier H; Sung H; White TJ; Wilson AF; Shaw P
Genet Epidemiol; 2018 Jun; 42(4):405-414. PubMed ID: 29682794
[TBL] [Abstract][Full Text] [Related]
43. Whole-exome sequencing of individuals from an isolated population implicates rare risk variants in bipolar disorder.
Lescai F; Als TD; Li Q; Nyegaard M; Andorsdottir G; Biskopstø M; Hedemand A; Fiorentino A; O'Brien N; Jarram A; Liang J; Grove J; Pallesen J; Eickhardt E; Mattheisen M; Bolund L; Demontis D; Wang AG; McQuillin A; Mors O; Wang J; Børglum AD
Transl Psychiatry; 2017 Feb; 7(2):e1034. PubMed ID: 28195573
[TBL] [Abstract][Full Text] [Related]
44. Intelligence in DSM-IV combined type attention-deficit/hyperactivity disorder is not predicted by either dopamine receptor/transporter genes or other previously identified risk alleles for attention-deficit/hyperactivity disorder.
Sonuga-Barke EJ; Brookes KJ; Buitelaar J; Anney R; Bitsakou P; Baeyens D; Buschgens C; Chen W; Christiansen H; Eisenberg J; Kuntsi J; Manor I; Meliá A; Mulligan A; Rommelse N; Müller UC; Uebel H; Banaschewski T; Ebstein R; Franke B; Gill M; Miranda A; Oades RD; Roeyers H; Rothenberger A; Sergeant J; Steinhausen HC; Thompson M; Taylor E; Asherson P; Faraone SV
Am J Med Genet B Neuropsychiatr Genet; 2008 Apr; 147(3):316-9. PubMed ID: 18023044
[TBL] [Abstract][Full Text] [Related]
45. Replication test for association of the IL-1 receptor antagonist gene, IL1RN, with attention-deficit/hyperactivity disorder.
Misener VL; Schachar R; Ickowicz A; Malone M; Roberts W; Tannock R; Kennedy JL; Pathare T; Barr CL
Neuropsychobiology; 2004; 50(3):231-4. PubMed ID: 15365221
[TBL] [Abstract][Full Text] [Related]
46. Psychiatric comorbidities in Asperger syndrome are related with polygenic overlap and differ from other Autism subtypes.
González-Peñas J; Costas JC; García-Alcón A; Penzol MJ; Rodríguez J; Rodríguez-Fontenla C; Alonso-González A; Fernández-Prieto M; Carracedo Á; Arango C; Parellada M
Transl Psychiatry; 2020 Jul; 10(1):258. PubMed ID: 32732888
[TBL] [Abstract][Full Text] [Related]
47. Mutations in sphingolipid metabolism genes are associated with ADHD.
Henriquez-Henriquez M; Acosta MT; Martinez AF; Vélez JI; Lopera F; Pineda D; Palacio JD; Quiroga T; Worgall TS; Deckelbaum RJ; Mastronardi C; Molina BSG; ; Arcos-Burgos M; Muenke M
Transl Psychiatry; 2020 Jul; 10(1):231. PubMed ID: 32661301
[TBL] [Abstract][Full Text] [Related]
48. Family-based association study on functional α-synuclein polymorphisms in attention-deficit/hyperactivity disorder.
Gerlach M; Sharma M; Romanos M; Lesch KP; Walitza S; Conzelmann HA; Krüger R; Renner TJ
Atten Defic Hyperact Disord; 2019 Mar; 11(1):107-111. PubMed ID: 30927235
[TBL] [Abstract][Full Text] [Related]
49. Whole-exome sequencing of 81 individuals from 27 multiply affected bipolar disorder families.
Forstner AJ; Fischer SB; Schenk LM; Strohmaier J; Maaser-Hecker A; Reinbold CS; Sivalingam S; Hecker J; Streit F; Degenhardt F; Witt SH; Schumacher J; Thiele H; Nürnberg P; Guzman-Parra J; Orozco Diaz G; Auburger G; Albus M; Borrmann-Hassenbach M; González MJ; Gil Flores S; Cabaleiro Fabeiro FJ; Del Río Noriega F; Perez Perez F; Haro González J; Rivas F; Mayoral F; Bauer M; Pfennig A; Reif A; Herms S; Hoffmann P; Pirooznia M; Goes FS; Rietschel M; Nöthen MM; Cichon S
Transl Psychiatry; 2020 Feb; 10(1):57. PubMed ID: 32066727
[TBL] [Abstract][Full Text] [Related]
50. Identification of genetic overlap and novel risk loci for attention-deficit/hyperactivity disorder and bipolar disorder.
O'Connell KS; Shadrin A; Bahrami S; Smeland OB; Bettella F; Frei O; Krull F; Askeland RB; Walters GB; Davíðsdóttir K; Haraldsdóttir GS; Guðmundsson ÓÓ; Stefánsson H; Fan CC; Steen NE; Reichborn-Kjennerud T; Dale AM; Stefánsson K; Djurovic S; Andreassen OA
Mol Psychiatry; 2021 Aug; 26(8):4055-4065. PubMed ID: 31792363
[TBL] [Abstract][Full Text] [Related]
51. Intergenerational Transmission of Education and ADHD: Effects of Parental Genotypes.
de Zeeuw EL; Hottenga JJ; Ouwens KG; Dolan CV; Ehli EA; Davies GE; Boomsma DI; van Bergen E
Behav Genet; 2020 Jul; 50(4):221-232. PubMed ID: 32026073
[TBL] [Abstract][Full Text] [Related]
52. Impact of autism-associated genetic variants in interaction with environmental factors on ADHD comorbidities: an exploratory pilot study.
Waltes R; Freitag CM; Herlt T; Lempp T; Seitz C; Palmason H; Meyer J; Chiocchetti AG
J Neural Transm (Vienna); 2019 Dec; 126(12):1679-1693. PubMed ID: 31707462
[TBL] [Abstract][Full Text] [Related]
53. An Ultraconserved Brain-Specific Enhancer Within ADGRL3 (LPHN3) Underpins Attention-Deficit/Hyperactivity Disorder Susceptibility.
Martinez AF; Abe Y; Hong S; Molyneux K; Yarnell D; Löhr H; Driever W; Acosta MT; Arcos-Burgos M; Muenke M
Biol Psychiatry; 2016 Dec; 80(12):943-954. PubMed ID: 27692237
[TBL] [Abstract][Full Text] [Related]
54. Association of attention-deficit/hyperactivity disorder with a candidate region for reading disabilities on chromosome 6p.
Couto JM; Gomez L; Wigg K; Ickowicz A; Pathare T; Malone M; Kennedy JL; Schachar R; Barr CL
Biol Psychiatry; 2009 Aug; 66(4):368-75. PubMed ID: 19362708
[TBL] [Abstract][Full Text] [Related]
55. Polygenic Risk and Neural Substrates of Attention-Deficit/Hyperactivity Disorder Symptoms in Youths With a History of Mild Traumatic Brain Injury.
Stojanovski S; Felsky D; Viviano JD; Shahab S; Bangali R; Burton CL; Devenyi GA; O'Donnell LJ; Szatmari P; Chakravarty MM; Ameis S; Schachar R; Voineskos AN; Wheeler AL
Biol Psychiatry; 2019 Mar; 85(5):408-416. PubMed ID: 30119875
[TBL] [Abstract][Full Text] [Related]
56. Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5.
Kustanovich V; Ishii J; Crawford L; Yang M; McGough JJ; McCracken JT; Smalley SL; Nelson SF
Mol Psychiatry; 2004 Jul; 9(7):711-7. PubMed ID: 14699430
[TBL] [Abstract][Full Text] [Related]
57. DRD4 rare variants in Attention-Deficit/Hyperactivity Disorder (ADHD): further evidence from a birth cohort study.
Tovo-Rodrigues L; Rohde LA; Menezes AM; Polanczyk GV; Kieling C; Genro JP; Anselmi L; Hutz MH
PLoS One; 2013; 8(12):e85164. PubMed ID: 24391992
[TBL] [Abstract][Full Text] [Related]
58. Investigation of the G protein subunit Galphaolf gene (GNAL) in attention deficit/hyperactivity disorder.
Laurin N; Ickowicz A; Pathare T; Malone M; Tannock R; Schachar R; Kennedy JL; Barr CL
J Psychiatr Res; 2008 Jan; 42(2):117-24. PubMed ID: 17166517
[TBL] [Abstract][Full Text] [Related]
59. Whole exome sequencing in extended families with autism spectrum disorder implicates four candidate genes.
Chapman NH; Nato AQ; Bernier R; Ankenman K; Sohi H; Munson J; Patowary A; Archer M; Blue EM; Webb SJ; Coon H; Raskind WH; Brkanac Z; Wijsman EM
Hum Genet; 2015 Oct; 134(10):1055-68. PubMed ID: 26204995
[TBL] [Abstract][Full Text] [Related]
60. Dense-map genome scan for dyslexia supports loci at 4q13, 16p12, 17q22; suggests novel locus at 7q36.
Field LL; Shumansky K; Ryan J; Truong D; Swiergala E; Kaplan BJ
Genes Brain Behav; 2013 Feb; 12(1):56-69. PubMed ID: 23190410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
